BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 26373873)

  • 1. Survival outcomes in liver transplant recipients with Model for End-stage Liver Disease scores of 40 or higher: a decade-long experience.
    Panchal HJ; Durinka JB; Patterson J; Karipineni F; Ashburn S; Siskind E; Ortiz J
    HPB (Oxford); 2015 Dec; 17(12):1074-84. PubMed ID: 26373873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of liver transplantation for end-stage biliary disease: A comparative study with end-stage liver disease.
    Lai YH; Duan WD; Yu Q; Ye S; Xiao NJ; Zhang DX; Huang ZQ; Yang ZY; Dong JH
    World J Gastroenterol; 2015 May; 21(20):6296-303. PubMed ID: 26034365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High model for end-stage liver disease score as a predictor of survival during long-term follow-up after liver transplantation.
    Suzuki H; Bartlett AS; Muiesan P; Jassem W; Rela M; Heaton N
    Transplant Proc; 2012 Mar; 44(2):384-8. PubMed ID: 22410023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival outcomes of right-lobe living donor liver transplantation for patients with high Model for End-stage Liver Disease scores.
    Chok KSh; Chan SC; Fung JY; Cheung TT; Chan AC; Fan ST; Lo CM
    Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):256-62. PubMed ID: 23742770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low, rather than high, body mass index confers increased risk for post-liver transplant death and graft loss: Risk modulated by model for end-stage liver disease.
    Bambha KM; Dodge JL; Gralla J; Sprague D; Biggins SW
    Liver Transpl; 2015 Oct; 21(10):1286-94. PubMed ID: 26097202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of Waitlist Mortality in Portopulmonary Hypertension.
    DuBrock HM; Goldberg DS; Sussman NL; Bartolome SD; Kadry Z; Salgia RJ; Mulligan DC; Kremers WK; Kawut SM; Krowka MJ; Channick RN
    Transplantation; 2017 Jul; 101(7):1609-1615. PubMed ID: 28207639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should a lower quality organ go to the least sick patient? Model for end-stage liver disease score and donor risk index as predictors of early allograft dysfunction.
    Croome KP; Marotta P; Wall WJ; Dale C; Levstik MA; Chandok N; Hernandez-Alejandro R
    Transplant Proc; 2012 Jun; 44(5):1303-6. PubMed ID: 22664005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Liver Transplant-Related Survival Benefit in Patients With Versus Without Hepatocellular Carcinoma in the United States.
    Berry K; Ioannou GN
    Gastroenterology; 2015 Sep; 149(3):669-80; quiz e15-6. PubMed ID: 26021233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: the national experience.
    Schwartz JJ; Pappas L; Thiesset HF; Vargas G; Sorensen JB; Kim RD; Hutson WR; Boucher K; Box T
    Liver Transpl; 2012 Apr; 18(4):423-33. PubMed ID: 22250078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.
    Gadiparthi C; Cholankeril G; Yoo ER; Hu M; Wong RJ; Ahmed A
    Dig Dis Sci; 2018 Jun; 63(6):1647-1653. PubMed ID: 29611079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consequences of the implementation of the Model for End-stage Liver Disease system for liver allocation in Brazil.
    Pestana RC; Baracat EI; Massarollo PC; Pereira LA; Szutan LA
    Transplant Proc; 2013; 45(6):2111-4. PubMed ID: 23747144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival after liver transplantation in the United States: a disease-specific analysis of the UNOS database.
    Roberts MS; Angus DC; Bryce CL; Valenta Z; Weissfeld L
    Liver Transpl; 2004 Jul; 10(7):886-97. PubMed ID: 15237373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of MELD score implementation on liver allocation: experience at a Brazilian center.
    da Silva Machado AG; de Medeiros Fleck A; Marroni C; Zanotelli ML; Cantisani G; de Mello Brandão AB
    Ann Hepatol; 2013; 12(3):440-7. PubMed ID: 23619261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
    Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining long-term outcomes with living donor liver transplantation in North America.
    Olthoff KM; Smith AR; Abecassis M; Baker T; Emond JC; Berg CL; Beil CA; Burton JR; Fisher RA; Freise CE; Gillespie BW; Grant DR; Humar A; Kam I; Merion RM; Pomfret EA; Samstein B; Shaked A
    Ann Surg; 2015 Sep; 262(3):465-75; discussion 473-5. PubMed ID: 26258315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Elderly Allografts in Liver Transplantation.
    Paterno F; Wima K; Hoehn RS; Cuffy MC; Diwan TS; Woodle SE; Abbott DE; Shah SA
    Transplantation; 2016 Jan; 100(1):153-8. PubMed ID: 26154390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aging of Liver Transplant Registrants and Recipients: Trends and Impact on Waitlist Outcomes, Post-Transplantation Outcomes, and Transplant-Related Survival Benefit.
    Su F; Yu L; Berry K; Liou IW; Landis CS; Rayhill SC; Reyes JD; Ioannou GN
    Gastroenterology; 2016 Feb; 150(2):441-53.e6; quiz e16. PubMed ID: 26522262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor-Model for End-Stage Liver Disease and donor-recipient matching in liver transplantation.
    Vitale A; Ramirez Morales R; dalla Bona E; Scopelliti M; Zanus G; Neri D; d'Amico F; Gringeri E; Russo F; Burra P; Angeli P; Cillo U
    Transplant Proc; 2011 May; 43(4):974-6. PubMed ID: 21620029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver Transplantation for Hepatitis B in Early Adulthood: Analysis of the United Network for Organ Sharing Database.
    Rifai G; Anani A; Hanouneh IA; Mohamad B; Matloob A; Lopez R; Zein NN; Alkhouri N
    Transplant Proc; 2016 Dec; 48(10):3362-3367. PubMed ID: 27931582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of model for end-stage liver disease exceptions for donation after cardiac death graft recipients relisted for liver transplantation.
    Maduka RC; Abt PL; Goldberg DS
    Liver Transpl; 2015 Apr; 21(4):554-60. PubMed ID: 25597393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.